NIOD

NIOD, short for Non-Invasive Options in Dermal Science, is a Canadian skincare brand based in Toronto. It was created as a project within DECIEM, the multi-brand company founded by Brandon Truaxe, and is co-credited to Truaxe and Nicola Kilner. Editorial sources date its launch to 2015 [11], a year ahead of its better-known sister brand, The Ordinary; a parent record places the founding in 2014, but the 2015 date is the one most consistently reported. The brand positions itself at the higher, more clinical end of DECIEM's portfolio and remains active under The Estée Lauder Companies, which became its sole owner in 2024 [12].

The name doubles as the brand's thesis. NIOD describes its purpose as being "at the very edge of science without regard to brands, trends, criticisms and words," and frames itself as a deliberately selective proposition rather than a mass one.

NIOD grew out of DECIEM, which Truaxe established in Toronto. The company's own account traces its name to "decima," the Latin word for ten in sequence, reflecting a strategy of building many brands at once; as Truaxe put it, "we decided to do 10 things at once and called our craziness DECIEM." DECIEM's founding is generally given as 2013, though Wikipedia records the company being incorporated in 2012 as "The Abnormal Beauty Company," with its first product line appearing in 2013 [8].

Truaxe, born Ali Roshan in Tehran in 1978, was an Iranian-Canadian computer scientist who had built and sold a software company before moving into cosmetics, and had earlier worked on the skincare ventures Euoko and Indeed Labs [8]. By the company's telling, the idea for DECIEM took shape after a skincare-lab internship left him frustrated "at the lack of passion, transparency, or insight when beauty products were being developed." His co-founder, Nicola Kilner, met him in 2011 while working as a beauty buyer at Boots in the United Kingdom, and later rose to lead the company.

NIOD is owned through DECIEM Beauty Group, which operates under The Estée Lauder Companies (ELC); the brand's own supply-chain page confirms ELC as the parent group. ELC built that ownership in stages. It first invested in 2017, taking a roughly 28% equity stake for $50 million [8]. In 2021 it raised its holding to a majority position of about 76%, in a step reported at around $1 billion [12]. ELC then completed the purchase of the remaining interests on 31 May 2024 for approximately $860 million, bringing its total investment across the three rounds to roughly $1.7 billion [12]. (A parent record had described full ownership as occurring in 2021; the 2021 transaction was in fact only a majority stake, with full ownership completed in 2024.)

On announcing the final stage, Kilner said that "today The Estée Lauder Companies becomes the forever home of Deciem." Through ELC, NIOD sits alongside brands including Estée Lauder, Clinique, La Mer, M·A·C Cosmetics, Jo Malone London and Aveda, as well as its closer DECIEM sibling, The Ordinary.

NIOD's stated approach is to lead with formulation over messaging. Truaxe articulated the brand's premise bluntly: "in the business of beauty, perception is more powerful than reality, and it is for this reason that brands — especially those in functional beauty — prioritize what they say ahead of what they do." Against that, the company lists values such as scientific advancement, accountability over perception, and being "innovation-focused rather than marketing-driven."

In the wider market, NIOD is most often framed in relation to The Ordinary, which launched in 2016 and became one of the defining direct-to-consumer skincare lines of the late 2010s [11]. Refinery29 called NIOD "The Ordinary's much chicer older sister," noting that the two share similar dropper-bottle packaging but that NIOD's formulations are pitched as more sophisticated and priced somewhat higher [9]. The same profile described NIOD as "one of skincare's best kept secrets," appealing to "beauty industry insiders, dermatologists and makeup artists" [9].

The brand organises its range around three steps — Prepare, Optimise and Protect — spanning cleansers, mists, serums, treatments, moisturisers and masques, with skincare as its sole category. Its formulations draw on ingredients such as copper peptides (GHK-Cu), multi-molecular hyaluronic acid, superoxide dismutase, amino acids and encapsulated and liposomal delivery systems.

A set of core products anchors the line, referred to as the "Core Four": the Copper Amino Isolate Serum 3 1:1 (CAIS3), the Multi-Molecular Hyaluronic Complex (MMHC), the Fractionated Eye-Contour Concentrate (FECC) and the Copper Amino Isolate Lipid 1% (CAIL) [11]. The brand says the FECC draws on "28 clinical technologies" to target signs of ageing around the eyes. A Superoxide Dismutase 3 Enzyme Mist also features prominently among its better-known items. In editorial coverage, the Copper Amino Isolate Serum and a superoxide-dismutase mist are repeatedly named as the products skincare enthusiasts associate most with NIOD [9].

On sustainability, DECIEM frames its position with unusual caution for the category, stating plainly that "DECIEM is not a sustainable beauty company, as we don't have all the answers — yet," while listing five focus areas including responsible packaging, climate change, waste management, responsible sourcing and water conservation.

DECIEM was the subject of significant disruption in 2018, when Truaxe was removed as chief executive. After he ordered the company's operations to shut down through a series of Instagram posts, ELC — by then a minority investor — pursued legal action, and Kilner was appointed sole CEO [8]. Truaxe died in Toronto in January 2019 at the age of 40 [8]. Kilner remained with the company and continued to lead it through its later expansion.

NIOD is active. Its site operates as a full e-commerce store, and the brand is sold direct-to-consumer, through DECIEM stores, and via third-party prestige retailers such as Cult Beauty. Since ELC completed full ownership in 2024, NIOD has been positioned for further growth; Business of Fashion covered a relaunch of the brand that year, framing it as a higher-priced counterpart to The Ordinary [13].